FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/12/2024
Voltar para busca
Dado oficial do USPTO
FOLDIKINE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
FOLDIKINE
ST13
US500000079366890Classe
1, 5, 42
Pedido
79366890
Registro
7334166
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
25
Atualização mais recente
21/12/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
07/12/2022
Data de registro
26/03/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/03/2024
Última transação
26/03/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
12
Localização do titular
ES
Examinador
MORRIS, KRISTINA
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
FUNDACIÓ CENTRE DE REGULACIÓ GENÒMICA
Representantes
Stephanie N. Nikitenko IpHorgan Ltd
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Protein in raw material form for scientific and medical research; proteins for use in science; proteins for use in industry; proteins for use in the manufacture of cosmetics; biological preparations for industry and science; biological preparations for use in the manufacture of cosmetics; immunomodulatory biological molecules and chimeras thereof for scientific useother than for medical or veterinary use; immunomodulatory biological molecules and chimeras thereof for industrial useother than for medical or veterinary use; immunomodulatory biological molecules and chimeras thereof for use in the manufacture of cosmetics; immunomodulatory biological molecules and chimeras thereof for use in laboratoriesother than for medical or veterinary use; culture media for microbiology for scientific and research use; culture media of eukaryotic cellsin particularimmunelymphoid and myeloid cells for scientific and research use
Classe 5
Pharmaceutical preparations for the treatment of immune-mediated diseases; veterinary preparations for the treatment of immune-mediated diseases; biological preparations for medical use for the treatment of immune-mediated diseases; biological preparations for veterinary purposes for the treatment of immune-mediated diseases; immunomodulators; immunosuppressants; immunostimulants; growth factorscell growth media for growing cells for medical or clinical use; cell survival factorsnamely cell growth media for growing cells for medical or clinical use; pharmaceutical and veterinary preparations for regulating the immune system; pharmaceutical and veterinary preparations for the treatment and/or prevention of diseases and disorders of the immune system or those affecting the immune system; regulatory proteins for medical and veterinary use in the nature of protein arrays for medical use and medical diagnosis purposes
Classe 42
Scientific and technological servicesscientific research ; research and development of products; design and development of biologicalpharmaceutical and veterinary products; medicalpharmacological and veterinary research services; research related to molecular science; research and development services in immunology; research and development services in the field of immunohistology; research and development services with respect to immunomodulatory molecules; laboratory research services in relation to the production of immunomodulatory biological molecules and chimeras thereof; software design and development; informationadvisoryconsultancy relating to the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
15/11/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
14/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/06/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
26/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/01/2024
PUBO
PUBLISHED FOR OPPOSITION
09/01/2024
GPNX
NOTIFICATION PROCESSED BY IB
08/01/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/12/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/11/2023
RFNT
REFUSAL PROCESSED BY IB
25/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/10/2023
RFRR
REFUSAL PROCESSED BY MPU
03/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/09/2023
CNRT
NON-FINAL ACTION WRITTEN
20/09/2023
DOCK
ASSIGNED TO EXAMINER
13/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
14/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/04/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/04/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FOLDIKINE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.